F
Fabio Pammolli
Researcher at Polytechnic University of Milan
Publications - 252
Citations - 9333
Fabio Pammolli is an academic researcher from Polytechnic University of Milan. The author has contributed to research in topics: Health care & Competition (economics). The author has an hindex of 42, co-authored 245 publications receiving 8258 citations. Previous affiliations of Fabio Pammolli include Boston University & University of Siena.
Papers
More filters
Posted Content
On the Size Distribution of Business Firms
TL;DR: The size distribution of business firms is explained using number and size of firms' constituent components as discussed by the authors, which is a lognormal distribution multiplied by a stretching factor which can lead to a Pareto upper tail.
Journal ArticleDOI
The productivity crisis in pharmaceutical R&D
TL;DR: This study examines the decline of R&D productivity in pharmaceuticals in the past two decades and shows that this decline is associated with an increasing concentration ofR&D investments in areas in which the risk of failure is high, which correspond to unmet therapeutic needs and unexploited biological mechanisms.
Journal ArticleDOI
Economic and social consequences of human mobility restrictions under COVID-19.
Giovanni Bonaccorsi,Francesco Pierri,Matteo Cinelli,Andrea Flori,Alessandro Galeazzi,Francesco Porcelli,Ana Lucia Schmidt,Carlo Michele Valensise,Antonio Scala,Walter Quattrociocchi,Fabio Pammolli +10 more
TL;DR: A massive analysis of the impact of lockdown measures introduced in response to the spread of novel coronavirus disease 2019 (COVID-19) on socioeconomic conditions of Italian citizens is presented and evidence of a segregation effect is found, since mobility contraction is stronger in municipalities in which inequality is higher and for those where individuals have lower income per capita.
Posted Content
A Comparison of U.S. and European University-Industry Relations in the Life Sciences
TL;DR: It is shown that the roles of large and small firms differ in the United States and Europe, arguing that the greater heterogeneity of the U.S. system is based on much closer integration of basic science and clinical development.
Journal ArticleDOI
A Comparison of U.S. and European University-Industry Relations in the Life Sciences
TL;DR: In this article, the authors draw on diverse data sets to compare the institutional organization of upstream life science research across the United States and Europe, and demonstrate that innovative research in biomedicine has its origins in regional clusters in the U.S. and Europe.